-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Bio-Revolution: 3 Biotech Stocks With Breakthrough Potential
Amidst the optimistic expectations for the biotechnology market, it's worth taking a closer look at the promising biotech stocks.
Chief Strategy Officer Denise Faltischek Is Buying Up Tilray (TLRY) Stock
TLRY stock insiders are on a buying spree. These insiders include Tilray's Chief Strategy Officer, CEO and Chief Financial Officer.
Why Is Aravive (ARAV) Stock Down 52% Today?
Aravive stock is falling hard on Thursday after the company announced plans to voluntarily delist shares of ARAV from the Nasdaq!
Why Is Marpai (MRAI) Stock Up 27% Today?
Marpai stock is rising higher on Thursday after the company announced a securities purchase agreement for MRAI with certain insiders.
Why Pfizer Stock Is a Fantastic Pharma Comeback Candidate
If Pfizer can seize a piece of the obesity-drug pie, PFE stock has the potential to rebound sharply this year.
Tilray CEO Irwin Simon Is Buying Up TLRY Stock
Tilray CEO Irwin Simon has shown his conviction in the company by making his first insider buy in almost four years.
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Why Is Elevai Labs (ELAB) Stock Up Today?
Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock.
Why Is Allakos (ALLK) Stock Down 57% Today?
Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing.
